Emerald Clinical

Emerald Clinical Emerald Clinical is a global full-service CRO with 25+ years’ experience.

We deliver Phase I–IV & real-world studies worldwide, partnering with biotech & top pharma to advance therapies in Renal, Oncology, Autoimmune & more. With over 20 years of experience and more than 500 people managing 38 geographical locations throughout the Asia-Pacific region, USA, and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration and post-marketing trials.

Better renal outcomes start with better development decisions.For over 25 years, Emerald Clinical has helped sponsors na...
18/09/2026

Better renal outcomes start with better development decisions.

For over 25 years, Emerald Clinical has helped sponsors navigate the complexities of renal drug development through deep scientific expertise, tailored trial strategies, and operational excellence.

The result: faster start-up, stronger patient recruitment, and studies designed to deliver meaningful clinical and regulatory outcomes.

Contact us now - https://emeraldclinical.com/contact-us/?utm_campaign=ASN+2026&utm_source=facebook&utm_medium=organic_social&utm_content=1789719300

17/09/2026

Looking for a strategic partner for your next cardio, renal, or metabolic study?

Watch Chelsey Hehl, Therapeutic Franchise Head, share how Emerald Clinical supports sponsors with end-to-end clinical development solutions, from study strategy and startup through patient recruitment, trial ex*****on, and delivery.

We'd welcome the opportunity to meet and discuss your development goals and how Emerald Clinical can support your next trial at the Obesity & Innovation Conference in Boston, September 23-24.

Connect with Chelsey Hehl, Therapeutic Franchise Head or Jack Sullivan, Associate Director, Business Development to schedule a time to meet onsite through the partnering app or here: https://emeraldclinical.com/contact-us/?utm_campaign=&utm_source=facebook&utm_medium=organic_social&utm_content=1789632900

16/09/2026

Heading to Precision in Clinical Trials Summit in San Diego, CA on October 12–13, 2026?

Meet with Maha Rinaudo, Senior Director, Business Development, to learn how Emerald Clinical can help accelerate your clinical development program through:

🧬 Deep APAC expertise - with local regulatory and operational knowledge
🧬 Extensive access to leading sites and patient populations across China
🧬 Rapid study start-up, accelerated enrollment, and proven regulatory strategies
🧬 Early-phase capabilities in Australia and China, supporting First-in-Human (FIH) through Proof-of-Concept studies

Whether you're looking to expand into APAC, leverage China's clinical trial landscape, or speed early-phase development, we're ready to help.

📅 Schedule time to meet with Maha onsite through the partnering app or here https://emeraldclinical.com/contact-us/?utm_campaign=&utm_source=facebook&utm_medium=organic_social&utm_content=1789546501

Happy Malaysia Day! Celebrating the spirit, resilience, and diversity of Malaysia — thank you to our Malaysian team for ...
16/09/2026

Happy Malaysia Day! Celebrating the spirit, resilience, and diversity of Malaysia — thank you to our Malaysian team for your dedication and impact.

We are sharing the exact "APAC Integration Checklist" to cut duplication and accelerate your global filing readiness. Jo...
15/09/2026

We are sharing the exact "APAC Integration Checklist" to cut duplication and accelerate your global filing readiness.

Join in our webinar and find the coordinated, sequenced strategy that eliminates duplication, de-risks Phase II/III, and strengthens your global filing package.

🚨 We are just one week away.

Join our webinar on Sept 22 to walk through the regulatory pathways, real-world case examples, and common pitfalls to avoid.

👉 Register link here - https://emeraldclinical.com/apac-oncology-trials-accelerate-global-development-timelines/?utm_campaign=webinar+-+APAC+Oncology+Trials&utm_source=facebook&utm_medium=organic_social&utm_content=1789460101

Oncology innovation is moving fast. Clinical development needs to move with it.Emerald Clinical helps sponsors evaluate ...
14/09/2026

Oncology innovation is moving fast. Clinical development needs to move with it.

Emerald Clinical helps sponsors evaluate ADCs, bispecifics and novel combinations through Western-anchored, Asia-enabled programmes that expand access to patients and specialist sites across key global markets.

The result: fewer recruitment bottlenecks, earlier insights and more informed development decisions.

💡 Heading to ESMO Madrid 2026? Connect with Emerald Clinical to see how we can de-risk your asset and accelerate your clinical readiness.

🔗 https://emeraldclinical.com/meet-us-at-esmo-madrid-2026/?utm_campaign=&utm_source=facebook&utm_medium=organic_social&utm_content=1789404060

Visit Booth D-85, let's accelerate your trial! 2026 marks the 40th anniversary of Bio Japan! From 7–9 October 2026 in Yo...
14/09/2026

Visit Booth D-85, let's accelerate your trial!

2026 marks the 40th anniversary of Bio Japan! From 7–9 October 2026 in Yokohama, our team will be at Booth D-85 ready to discuss how our global, full‑service CRO capabilities can accelerate your drug development programmes.

With over 25 years of experience in Phase I–IV trials and real‑world studies across all therapeutic areas, we bring deep expertise to:

• Renal – your preferred CRO for renal innovation: 100+ studies in 70+ countries,

• Oncology – 700+ oncology trials completed

• Autoimmune – dedicated teams that tackle patient heterogeneity, complex regulatory

We look forward to meeting you in Yokohama. Let’s explore how we can support your next trial.

Meet us at Bio Japan 2026 - https://emeraldclinical.com/meet-us-at-bio-japan-2026/?utm_campaign=Bio+Japan+2026&utm_source=facebook&utm_medium=organic_social&utm_content=1789373700

We are thrilled to welcome you join our "APAC Oncology Trials: Accelerate Global Development Timelines" on September 22....
10/09/2026

We are thrilled to welcome you join our "APAC Oncology Trials: Accelerate Global Development Timelines" on September 22.

📍 https://emeraldclinical.com/apac-oncology-trials-accelerate-global-development-timelines/?utm_campaign=webinar+-+APAC+Oncology+Trials&utm_source=facebook&utm_medium=organic_social&utm_content=1789028100

Luke Gill (VP, Global Head of Oncology at Emerald Clinical), Will Chen (Head of Regulatory Affairs at Emerald Clinical) and Rokuya Nochi (Executive Officer at EPS Corporation), they will reshape your development strategy:

•"Should I file my China IND before or after my Australian CTA?"

•"How do I align Japanese GCP requirements with my global monitoring plan?"

If you are a clinical operations lead, regulatory strategist, or portfolio manager, this is the session you cannot miss!

Address

#32-01 300 Beach Road, The Concourse
Singapore
199555

Website

Alerts

Be the first to know and let us send you an email when Emerald Clinical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category